Cancer charity appoints former BHF Wales head as CEO

Cancer Research Wales has appointed Adam Fletcher as chief executive.

He joins from the British Heart Foundation Cymru, which he has led for the last six years.

Prior to joining BHF he was an academic, carrying out research and teaching at Cardiff University and the London School of Hygiene and Tropical Medicine.

"It is a huge privilege to take on the role of Chief Executive of Cancer Research Wales", said Fletcher.

"I look forward to meeting all the fundraisers and all the donors and volunteers across Wales, and developing new partnerships to ensure Cancer Research Wales can continue to fund the best scientists and save more lives.

“It’s an exciting time, with new methods of early detection and treatment being developed and tested across Wales, and its vital that progress doesn’t stall now.

“My own family has been affected by cancer and I know how scary it is for people following a diagnosis. My ambition is to make Wales a world-leader in cancer research with the Welsh NHS pioneering new services.”



Cancer Research Wales chair Gavin Moore added: “Adam brings a huge range of relevant experience to the role, gained through over two decades of working in research, academia and the Welsh charity sector and most recently leading the British Heart Foundation for Wales.

“The Board of Trustees and I are looking forward to working with Adam to lead the charity through its next exciting stage of growth and progressing our key aim of supporting world class cancer research in Wales.”



Share Story:

Recent Stories


Charity Times Awards 2023

Banking & charities: what's causing the rift & can we fix it?
The strained and deteriorating relationship between banking/finance and nonprofits has been well documented by the charity sector, so what does banking/finance have to say in response? Why isn't the relationship improving and how can it be fixed? With 30+ years of collective experience through working in international payments, IPT Africa's CEO Mark O'Sullivan and COO Daniel Goodwin give their insider's view